Related Experiment Video
Updated: Jun 4, 2026
09:05
Flow-pattern Guided Fabrication of High-density Barcode Antibody Microarray
Published on: January 6, 2016
Multiplexed detection of antibodies using programmable bead arrays.
1Cancer Vaccine Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. kanderson@partners.org
Methods in Molecular Biology (Clifton, N.J.)
|March 4, 2011
Summary
This study introduces a novel method for detecting antibodies in patient sera using in vitro protein production and bead arrays. This approach enables rapid, multiplexed screening for infectious diseases, autoimmunity, and cancer biomarkers.
Area of Science:
- Biotechnology
- Immunology
- Proteomics
Background:
- Antibody detection in sera is crucial for diagnosing infectious diseases, autoimmune disorders, and cancer.
- Current proteomic methods and ELISAs have limitations in cost, scalability, and multiplexing capabilities for large-scale serum screening.
Purpose of the Study:
- To develop a rapid, reproducible, and multiplexed assay for simultaneous antibody detection against multiple antigens in numerous serum samples.
- To overcome the limitations of traditional methods for biomarker validation studies.
Main Methods:
- Coupled in vitro protein production with anti-tag capture onto bead arrays.
- Simultaneous screening of fewer than 100 antigens with hundreds or thousands of sera.
Main Results:
- Demonstrated a novel assay for rapid, multiplexed antibody detection in sera.
- The method is adaptable for various protein-specific antibody targets.
Conclusions:
- The developed assay offers a scalable and efficient solution for antibody detection in clinical discovery and biomarker validation.
- This technique facilitates the identification of antibodies related to infectious agents, autoimmune conditions, and cancer.
